About Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
3
Heart Centre Rotenburg
1
University Hospital, Saarland
1
Clinical Trials at Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
During the past decade, Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
P E P C A D II, The Paclitaxel-Eluting PTCA-Balloon Catheter in Coronary Artery Disease to Treat In-Stent Restenoses
2005-11-01
2007-12-01
Completed
120
PEPCAD I. The Paclitaxel-Eluting PTCA-Balloon Catheter to Treat Small Vessel
2006-01-01
2012-09-01
Completed
120
A Study of Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)
2011-06-25
2016-06-25
Completed
485
Evaluation of Long-Term Safety of Pirfenidone (Esbriet) in Participants With Idiopathic Pulmonary Fibrosis (IPF)
2012-02-16
2016-09-15
Completed
1,009
A Study to Evaluate the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Participants With Non-Small Cell Lung Cancer (NSCLC)
2017-09-22
2024-04-27
Recruiting
1,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie"
#1 collaborator was "B. Braun Melsungen AG" with 2 trials as a collaborator and "Clinical Research Institute, Center for Cardiovascular Disease Rotenburg a.d.F." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
According to Clinical.Site data, the most researched conditions in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" are
"Coronary Stenosis" (1 trials), "Idiopathic Pulmonary Fibrosis" (1 trials), "In-Stent Restenosis" (1 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Non-Squamous Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
Most popular intervention types in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" are "Drug" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Docetaxel" (2 trials), "Pemetrexed" (2 trials), "Alectinib" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
The vast majority of trials in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie
Currently, there are NaN active trials in "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".